The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing ...
The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood ...
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...
A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients treated at New York hospitals on Wednesday.
With the right structure, Americans will roll up their sleeves, do the science, and trust the result,” Manoush Zomorodi ...
Relatively speaking, the least controversial application of human embryo genome editing is to use it to try to prevent ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and ...
Pfizer disclosed that an experimental lung cancer drug it hoped could replace a widely used chemotherapy fell short in a clinical trial, STAT writes. Expectations had been high that the drug, ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...
EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart ...
An abandoned heart-failure trial offers a rare window into devices that the FDA deems "breakthrough" but never reach patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results